How many institutions held TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in Q2 2024?

34 institutional investors reported TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share for Q2 2024. Use the holders table for investor-level position and value details.

TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Q: What does CUSIP 88338N206 represent in this 13F holders report?

CUSIP 88338N206 is the security identifier for TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 88338N206

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 3,408,566
Total 13F value: $5,487,879
Share change: +31,516
Put/Call ratio: 1.1%
SEC-reported price per share: $1.61
Number of holders: 34
Value change: -$167
Number of buys: 8
Number of sells: 19
Shares outstanding: 11,627,985

Security key

88338N206

Report period

Q2 2024

Institutions

Top holders

TXMD full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 TherapeuticsMD, Inc. SEC filings TherapeuticsMD, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 88338N206

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Rubric Capital Management LP

Disclosed value leader

John C.k. Milligan IV

Comparable rows

0/15

Latest evidence

31 Mar 2024

3/4/5 13F Highest disclosed value: $12,698,322 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

John C.k. Milligan IV has the largest disclosed position value at $12.7M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens John C.k. Milligan IV's linked filing trail.

Disclosed position value Top 5

Rubric Capital Management LP $6.72M

John C.k. Milligan IV $12.7M

Hugh O'Dowd $11.42M

Robert G. Finizio $5.31M

James Darecca $1.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Rubric Capital Management LP	3/4/5 13F Director, Other*, 10%+ Owner · Company 3/4/5 13F	— denominator unverified	$6,718,950 2,946,908 shares	—	15 Nov 2023
John C.k. Milligan IV	3/4/5 Secretary/CEO of subsidiary 3/4/5	— mixed-class rows	$12,698,322 5,542,076 shares mixed-class rows	—	10 May 2021
Hugh O'Dowd	3/4/5 Chief Executive Officer 3/4/5	— mixed-class rows	$11,415,713 4,250,000 shares mixed-class rows	—	31 Mar 2022
Robert G. Finizio	3/4/5 CEO, Director 3/4/5	— mixed-class rows	$5,305,888 2,240,000 shares mixed-class rows	—	01 Jul 2021
James Darecca	3/4/5 Chief Financial Officer 3/4/5	— mixed-class rows	$1,857,402 558,163 shares mixed-class rows	—	10 Aug 2021
Edward Borkowski	3/4/5 EVP, Operations 3/4/5	— mixed-class rows	$1,326,472 560,000 shares mixed-class rows	—	01 Jul 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,408,566

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

-9

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend